Citation:Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM 2010

Citation

Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Australas J Dermatol 2010 May;51(2):99-105 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20546215.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM 2010	What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?	Annie Bygrave	completed
Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM 2010 2	What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?	Dr Albert Chetcuti BTech(Biotech) Hons, PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|]] (compare critical appraisals)
• [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|]] (compare critical appraisals)

Cited by

1. 10.1 The role of topical treatments in the treatment of keratinocyte cancer